Instituto Nacional de Controle de Qualidade em Saúde (INCQS), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Laboratório de Difteria e Corinebactérias de Importância Clínica (LDCIC), Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Antonie Van Leeuwenhoek. 2020 Apr;113(4):589-592. doi: 10.1007/s10482-019-01353-w. Epub 2019 Nov 18.
The resistance to fluoroquinolones in corynebacteria is due to mutations occurring in the quinolone-resistance-determining region (QRDR) of the gyrA gene encoding the enzyme gyrase A subunit. In recent years we can observe an increasing number of infections caused by multidrug-resistant Corynebacterium striatum, Corynebacterium jeikeium and Corynebacterium urealyticum, including wide range of disorders, such as invasive infections. In this study 14 Corynebacterium spp. isolated from intravenous sites were sequenced and new combinations of mutations in the QRDR of the gyrA gene were found in C. jeikeium and C. urealyticum. Nowadays, no study comparing mutations in this region and the susceptibility to fluoroquinolones in C. jeikeium and C. urealyticum has been described. All the isolates that showed double mutation (position 87 and 91) in the QRDR gyrA gene had high MIC to the fluoroquinolones tested.
棒状杆菌对氟喹诺酮类药物的耐药性是由于喹诺酮类药物耐药决定区(QRDR)中编码酶回旋酶 A 亚基的 gyrA 基因发生突变所致。近年来,我们可以观察到越来越多的由多药耐药的棒状杆菌引起的感染,包括多种疾病,如侵袭性感染。在这项研究中,从静脉部位分离出的 14 株棒状杆菌进行了测序,并在 C. jeikeium 和 C. urealyticum 中发现了 gyrA 基因 QRDR 中新的突变组合。目前,尚无关于 C. jeikeium 和 C. urealyticum 中该区域突变与氟喹诺酮类药物敏感性的比较研究。所有在 QRDR gyrA 基因中显示双重突变(位置 87 和 91)的分离株对测试的氟喹诺酮类药物的 MIC 均较高。